XQ2, a Novel TPZ Derivative, Induced G2/M Phase Arrest and Apoptosis under Hypoxia in Non-Small Cell Lung Cancer Cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Bioscience, biotechnology and biochemistry

• Publication date

  2010-06-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1271/bbb.90889PMID 20530905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Induction of Mitochondrial Damage and Apoptosis in Human Leukemia HL-60 Cells Due to Electrolyzed-Reduced Water and Glutathione

  2009cited by this paper
• Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phase.

  2008cited by this paper
• A redox-silent analogue of tocotrienol inhibits hypoxic adaptation of lung cancer cells.

  2008cited by this paper
• Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.

  2008cited by this paper
• Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes.

  2007cited by this paper
• Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer.

  2006cited by this paper
• The cytotoxicity of naturally occurring styryl lactones.

  2006cited by this paper
• Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing.

  2005cited by this paper
• Stabilization of Hypoxia-inducible Factor-1α by Prostacyclin under Prolonged Hypoxia via Reducing Reactive Oxygen Species Level in Endothelial Cells*

  2005cited by this paper
• Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression.

  2005cited by this paper
• Tirapazamine Cytotoxicity for Neuroblastoma Is p53 Dependent

  2005cited by this paper
• Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.

  2005cited by this paper
• Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells

  2004cited by this paper
• A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression

  2004cited by this paper
• Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway.

  2003cited by this paper
• Mechanisms of caspase activation.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Decreasing Cellular Hydrogen Peroxide With Catalase Mimics the Effects of Hypoxia on the Sensitivity of the L-Type Ca2+ Channel to &bgr;-Adrenergic Receptor Stimulation in Cardiac Myocytes

  2002cited by this paper
• Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain.

  2001cited by this paper
• Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion

  2001cited by this paper
• Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

  2000cited by this paper
• Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia

  2000cited by this paper
• Induction of cell‐cycle arrest and apoptosis by a novel retinobenzoic‐acid derivative, TAC‐101, in human pancreatic‐cancer cells

  1999cited by this paper
• Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

  1999cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.

  1993cited by this paper

• An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.

  2017cites this paper
• Redox-Related Mechanisms to Rebalance Cancer-Deregulated Cell Growth.

  2016cites this paper
• Preclinical Evaluation of Oral Metronomic Topotecan and Pazopanib for the Treatment of Aggressive Extracranial Pediatric Solid Tumors

  2014cites this paper
• Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts.

  2013cites this paper
• Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy

  2012cites this paper
• Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells

  2011cites this paper